MEDBOX | Toolbox Johnson & Johnson

TOOLBOX

Advanced search

Create your MEDBOX

TOOLBOX

Advanced search

Create your MEDBOX

LIST OPTIONS

FILTER BY LANGUAGE

FILTER BY COUNTRY

SORT BY

RESULTS/PAGE

LIST TYPE

8 records

	Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine World Health Organization WHO (2022) C_WHO View PDF(82) Download (64) Add to my MEDBOX 6 June 2022 These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. This document has been updated: Version 6 June 2022 Tags: vaccine, johnson&Johnson, recommendations, approval, COVID-19, SARS-CoV-2, vector-basierter Impfstoff, Source: https://apps.who.int/iris/rest/bitstream
	Beschluss der STIKO zur 19. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung Vygen-Bonnet S, Koch J, Bogdan C, et al. (2022) C1 View PDF(150) Download (91) Add to my MEDBOX Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfempfehlung ist es, Personen, die eine COVID-19-Impfung mit einem der nicht in der EU zugelassenen Ganzvirusimpfstoffen (CoronaVac, Covilo und Covaxin) oder dem Vektor-basierten Impfstoff Sputnik V erhalten haben, mit einem Impfschutz auszustatten, der vergleichbar mit dem einer Grundimmunisierung plus Auffrischimpfung mit einem mRNA-Impfstoff ist Tags: Impfungen, COVID-19, Strategie, Verteilung, Ethik, Risikogruppen, Priorisierung, Deutschland, mRNA, vector-basierter Impfstoff, Astra Zeneca, Moderna, pfizer, Risiko, Sinusvenenthrombosen, Zweitimpfung, johnson&Johnson, pediatrics, Children, Adolescents, booster, Source: https://www.rki.de/DE/Content/Infekt/Epi
	Recomendaciones provisionales sobre el uso de la vacuna Ad26.COV2.S de Janssen contra la COVID-19 Organización Mundial de la Salud (2021) C_WHO View PDF(50) Download (35) Add to my MEDBOX Estas orientaciones provisionales se han elaborado a partir de las recomendaciones que hizo el Grupo de Expertos de la OMS en Asesoramiento Estratégico en materia de inmunización (SAGE) en su reunión extraordinaria del 15 de marzo de 2021 [1], y que fueron actualizadas en su reunión extraordinaria del 27 de mayo de 2021 [2] Tags: vaccine, johnson&Johnson, recommendations, approval, COVID-19, SARS-CoV-2, vector-basierter Impfstoff, Source: https://apps.who.int/iris/handle/10665/3
	Предварительные рекомендации для вакцины Janssen Ad26.COV2.S (‎COVID-19) Всемирная организация здравоохранения (2021) C_WHO View PDF(60) Download (37) Add to my MEDBOX Это временное руководство было разработано на основе рекомендаций Стратегической консультативной группы экспер-тов (СКГЭ) по иммунизации на ее внеочередном заседании 15 марта 2021 г. Tags: vaccine, johnson&Johnson, recommendations, approval, COVID-19, SARS-CoV-2, vector-basierter Impfstoff, Source: https://apps.who.int/iris/handle/10665/3
	Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 Ad26.COV2.S de Janssen : orientations provisoires, première publication Organisation Mondiale de la Santé OMS (2021) C_WHO View PDF(56) Download (38) Add to my MEDBOX Tags: vaccine, johnson&Johnson, recommendations, approval, COVID-19, SARS-CoV-2, vector-basierter Impfstoff, Source: https://apps.who.int/iris/handle/10665/3
	African Union and the Africa CDC’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC View PDF(52) Download (57) Add to my MEDBOX 7 June 2021 The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African Medicines Regulatory Harmonization (AMRH) Initiative, and the World Health Organisation’s (WHO) African Vaccine Regulatory Forum (AVAREF) to enable and provide support for an effective regulatory framework for COVID-19 Vaccines in Africa Tags: vaccine candidates, johnson&Johnson, COVID-19, SARS-CoV-2, Source: https://africacdc.org/download/african-u
	WHO recommendation Janssen–Cilag International NV (Belgium) COVID-19 Vaccine (Ad26.COV2-S [recombinant]) World Health Organization WHO (2021) C_WHO Open external link (415) Add to my MEDBOX Tags: vaccine, COVID-19, johnson&Johnson, Source: https://extranet.who.int/pqweb/vaccines/
	Emergency Used Authorization for Janssen COVID-19 Vaccine African Union; Africa CDC Centres for Disease Control and Prevention; World Health Organization WHO, et al. (2021) CC View PDF(56) Download (38) Add to my MEDBOX African Union and the Africa Centers for Disease Control and Prevention’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine 10 March 2021 Tags: johnson&Johnson, SARS-CoV-2, COVID-19, Vaccines, emergency use, Africa, Source: https://africacdc.org/download/african-u

8 records

8 records